Company Name:  Accretive Health Inc  Ticker Symbol:  ACHI  CIK Number:  0001472595  WWW Address:  
CEO:  Dr. Emad Rizk  No. of Employees:  0 
Common Issue Type:   Business Description: 

  Industry Information:   [more like this] 
 Price  Day Change  Bid  Ask  Open  High  Low  Volume  2.45  0.07  2.44  2.45  2.52  2.60  2.50  168907 
Market Cap (mil)  Shares Outstanding (mil)  Beta  EPS  DPS  P/E  Yield  52WksRange 
262.7  107.2  0.00  0.87  0.00  0.0  0.0  3.43  1.47 
 KEY FIGURES (Latest Twelve Months  LTM)  Yesterday's Close  2.52  $  PE Ratio  LTM  0.0  
Market Capitalisation  262.7  mil 
Latest Shares Outstanding  107.2  mil 
Earnings pS (EPS)  0.87  $ 
Dividend pS (DPS)  0.00  ¢ 
Dividend Yield  0.0  % 
Dividend Payout Ratio   % 
Revenue per Employee  35,985  $ 
Effective Tax Rate  0.0  % 
Float  90.9  mil 
Float as % of Shares Outstanding  0.8  % 
Foreign Sales   mil 
Domestic Sales  117  mil 
Selling, General & Adm/tive (SG&A) as % of Revenue  0.60  % 
Research & Devlopment (R&D) as % of Revenue  0.00  % 
Gross Profit Margin  44.1  % 
EBITDA Margin  108.8  % 
PreTax Profit Margin  115.8  % 
Assets Turnover  25.9  % 
Return on Assets (ROA)  18.6  % 
Return on Equity (ROE)  0.0  % 
Return on Capital Invested (ROCI)  0.0  % 
Current Ratio  0.5  
Leverage Ratio (Assets/Equity)   
Interest Cover   
Total Debt/Equity (Gearing Ratio)   
LT Debt/Total Capital  0.0  % 
Working Capital pS  0.99  $ 
Cash pS  0.00  $ 
BookValue pS  0.54  $ 
Tangible BookValue pS  2.03  $ 
Cash Flow pS  0.58  $ 
Free Cash Flow pS  0.78  $ 

KEY FIGURES (LTM): Price info 
Price/Book Ratio  4.29  
Price/Tangible Book Ratio  0.00  
Price/Cash Flow  4.0  
Price/Free Cash Flow  2.9  
P/E as % of Industry Group  0.0  % 
P/E as % of Sector Segment  0.0  % 
  Balance Sheet (at a glance) in Millions 
   DIVIDEND INFO  Type of Payment   
Dividend Rate  0.00 
Current Dividend Yield  0.0 
5Y Average Dividend Yield  
Payout Ratio  0.0 
5Y Average Payout Ratio  0.0 
 
 
 
 
 
  Share price performance previous 3 years 
   Share price performance intraday 
    PRICE/VOLUME  High  Low  Close  % Price Chg  % Price Chg vs. Mkt.  Avg. Daily Vol  Total Vol 
1 Week        12.0  13  175,158  773,137 
4 Weeks  2.60  1.88  1.95  29.2  30  400,426  7,608,100 
13 Weeks  2.60  1.47  2.00  26.0  24  259,254  16,333,053 
26 Weeks  2.60  1.47  2.55  1.2  6  196,237  24,922,101 
52 Weeks  3.43  1.47  2.50  0.8  11  180,627  45,337,469 
YTD  3.23  1.47    21.3  28  170,451  31,874,454 
Moving Average  5Days  10Days  10Weeks  30Weeks  200Days  Beta (60Mnth)  Beta (36Mnth) 
 2.39  2.31  1.95  2.14  2.32  0.00  0.00 
  GROWTH RATES  5Year Growh  R² of 5Year Growth  3Year Growth 
Revenue  0.28  0.0  0.18 
Income   0.0  
Dividend   0.0  
Capital Spending   NA  
R&D   NA  
Normalized Inc.   NA  
  CHANGES  YTD vs. Last YTD  Curr Qtr vs. Qtr 1Yr ago  Annual vs. Last Annual 
Revenue %    
Earnings %    
EPS %    
EPS $    
  SOLVENCY RATIOS  SHORTTERM SOLVENCY RATIOS (LIQUIDITY) 
Net Working Capital Ratio  23.00 
Current Ratio  0.5 
Quick Ratio (Acid Test)  0.5 
Liquidity Ratio (Cash)  0.89 
Receivables Turnover  16.0 
Average Collection Period  23 
Working Capital/Equity  0.0 
Working Capital pS  0.96 
CashFlow pS  0.25 
Free CashFlow pS  0.47 
FINANCIAL STRUCTURE RATIOS 
Altman's ZScore Ratio  0.99 
Financial Leverage Ratio (Assets/Equity)  0.0 
Debt Ratio  0.0 
Total Debt/Equity (Gearing Ratio)  0.00 
LT Debt/Equity  0.00 
LT Debt/Capital Invested  206.7 
LT Debt/Total Liabilities  0.0 
Interest Cover  0.0 
Interest/Capital Invested  0.00 
  VALUATION RATIOS  MULTIPLES 
PQ Ratio  0.00 
Tobin's Q Ratio  0.54 
Current P/E Ratio  LTM  0.00 
Enterprise Value (EV)/EBITDA  5.58 
Enterprise Value (EV)/Free Cash Flow  3.46 
Dividend Yield  0.0 
Price/Tangible Book Ratio  LTM  0.00 
Price/Book Ratio  LTM  4.29 
Price/Cash Flow Ratio  4.0 
Price/Free Cash Flow Ratio  LTM  2.9 
Price/Sales Ratio  0.00 
P/E Ratio (1 month ago)  LTM  
P/E Ratio (26 weeks ago)  LTM  
P/E Ratio (52 weeks ago)  LTM  
5Y High P/E Ratio  171.2 
5Y Low P/E Ratio  8.6 
5Y Average P/E Ratio  
Current P/E Ratio as % of 5Y Average P/E  85 
P/E as % of Industry Group  0.0 
P/E as % of Sector Segment  0.0 
Current 12 Month Normalized P/E Ratio  LTM  0.0 
PER SHARE FIGURES 
LT Debt pS  0.00 
Current Liabilities pS  0.00 
Tangible Book Value pS  LTM  2.03 
Book Value pS  LTM  0.54 
Capital Invested pS  1.99 
Cash pS  LTM  0.00 
Cash Flow pS  LTM  0.58 
Free Cash Flow pS  LTM  0.78 
Earnings pS (EPS)  0.87 
  OPERATING RATIOS  PROFITABILITY RATIOS 
Free Cash Flow Margin  38.46 
Free Cash Flow Margin 5YEAR AVG  22.56 
Net Profit Margin  0.7 
Net Profit Margin  5YEAR AVRG.  0.5 
Equity Productivity  0.55 
Return on Equity (ROE)  0.0 
Return on Equity (ROE)  5YEAR AVRG.  
Capital Invested Productivity  0.55 
Return on Capital Invested (ROCI)  0.0 
Return on Capital Invested (ROCI)  5YEAR AVRG.  
Assets Productivity  0.30 
Return on Assets (ROA)  0.2 
Return on Assets (ROA)  5YEAR AVRG.  0.1 
Gross Profit Margin  44.1 
Gross Profit Margin  5YEAR AVRG.  0.2 
EBITDA Margin  LTM  108.8 
EBIT Margin  LTM  116.0 
PreTax Profit Margin  0.8 
PreTax Profit Margin  5YEAR AVRG.  0.8 
Effective Tax Rate  0.8 
Effective Tax Rate  5YEAR AVRG.  0.5 
EFFICIENCY RATIOS 
Cash Conversion Cycle  447,559 
Revenue per Employee  35,985 
Net Income per Employee  
Average Collection Period  447,559 
Receivables Turnover  16.0 
Day's Inventory Turnover Ratio  
Inventory Turnover  0.0 
Inventory/Sales  0.0 
Accounts Payble/Sales  4.53 
Assets/Revenue  3.33 
Net Working Capital Turnover  1.11 
Fixed Assets Turnover  0.35 
Total Assets Turnover  0.3 
Revenue per $ Cash  1.13 
Revenue per $ Plant  4.31 
Revenue per $ Common Equity  0.00 
Revenue per $ Capital Invested  0.00 
Selling, General & Adm/tive (SG&A) as % of Revenue  63.9 
SG&A Expense as % of Revenue  5YEAR AVRG.  0.0 
Research & Devlopment (R&D) as % of Revenue  0.0 
R&D Expense as % of Revenue  5YEAR AVRG.  0.0 

      